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infected PBMC to adhere to endothelial cells and therefore
decrease the probability of infection due to the absence of viral
transfer between EHV-4-infected PBMC and endothelial cells. We
were able to show that the EHV-4 UL56 in comparison to its
counterpart in EHV-1 was able to downregulate VLA-4 on equine
dermal cells. Taken together, we conclude that systemic spread and
higher pathogenic potential of EHV-1 compared to EHV-4 is caused
by differences in their abilities to infect and/or reprogram mono-
nuclear cells with respect to virus transfer to endothelial cells.
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Equine herpesvirus type 1 (EHV-1) continues to cause severe
outbreaks of abortions and myeloencephalopathy in horses
despite widely used vaccination. The aim of this work was to
determine the effects of frequent vaccination with an inactivated
EHV vaccine on immune development in horses. Fifteen EHV-1
naïve mares were vaccinated a total of 5 times over a period of 8
months with intervals of 20, 60, 90 and 60 days between vaccine
administrations. Total antibody and antibody isotype responses
were evaluated with a new sensitive EHV-1 Multiplex assay to
glycoprotein C (gC) and gD for up to 14 months after initial
vaccination. Antibodies peaked after the ﬁrst two vaccine doses
and then declined despite a third administration of the vaccine.
The fourth vaccine dose was given at 6 months and the gC and gD
antibody titers increased again. Mixed responses with increasing
gC but decreasing gD antibody values were observed after the
ﬁfth vaccination at 8 months. IgG4/7 isotype responses mimicked
the total Ig antibody production to vaccination most closely.
Vaccination also induced short-lasting IgG1 antibodies to gC, but
not to gD. EHV-1-speciﬁc cellular immunity induced by vaccina-
tion developed slower than antibodies, was dominated by IFN-g
producing T-helper 1 (Th1) cells, and was signiﬁcantly increased
compared to pre-vaccination values after administration of 3
vaccine doses. Decreased IFN-g production and reduced Th1-cell
induction were also observed after the second and fourth vacci-
nation. Overall, repeated EHV vaccine administration did not al-
ways result in increasing immunity. The adverse effects on
antibody and cellular immunity that were observed here when
the EHV vaccine was given in short intervals might in part explain
why EHV-1 outbreaks are observed despite widely used vacci-
nation. The ﬁndings warrant further evaluation of immune re-
sponses to EHV vaccines to optimize vaccination protocols for
different vaccines and horse groups at risk.
179
Equine Herpesvirus-1 Interferes with Type-I IFN-
Mediated Immune Responses in vitro in Equine
Endothelial Cells
S. Sarkar, U.B.R. Balasuriya, D.W. Horohov, T.M. Chambers
Department of Veterinary Science, Maxwell H. Gluck Equine
Research Center, University of Kentucky, Lexington, KY 40546,
USA
Equine herpesvirus-1 (EHV-1) is one of the major viral pathogens
of equids causing respiratory disease, abortion and neurologicdisease. Recently, there have been increasing incidences of
neurologic disease caused by EHV-1 in many countries. Type-I
interferon (IFN) is considered to be the ﬁrst line of defense against
many viral pathogens. It has been reported earlier that EHV-1
infects the endothelial cells lining the blood vessels of the central
nervous system and induces vasculitis leading to neurologic signs
in horses. We have previously shown that the neuropathogenic
T953 strain of EHV-1 suppresses type-I IFN in equine endothelial
cells (EECs) (Sarkar et al., 2015). However, the antiviral effect of
type-I IFN in the endothelial cells has not been studied in detail.
We hypothesized that EHV-1 infection inhibits type-I IFN-
mediated antiviral response. In this study we investigated the
antiviral effect of type-I IFN against the neuropathogenic T953
strain of EHV-1 in vitro in EECs. To study the effect of type-I IFN,
sub-conﬂuent monolayers of EECs were stimulated with puriﬁed
recombinant equine IFN-a (rEqIFN-a) for 24 h before infecting
with T953 strain of EHV-1 or vesicular stomatitis virus expressing
green ﬂuorescent protein (VSV-GFP) at an MOI¼0.1. VSV-GFP was
used as a positive control for IFN-sensitive virus. At different
times post infection (pi), cell supernatants were collected and
titrated by plaque assay on rabbit kidney-13 cells to determine
the number of virus particles. In a separate experiment, rEqIFN-a-
treated EECs were resuspended into single cell suspensions and
an infectious center assay was performed to determine if rEqIFN-
a interfered with the infectivity of the IFN-treated cells. The re-
sults from both of the experiments demonstrated that T953 strain
of EHV-1 was partially resistant to the antiviral effect of exoge-
nously supplied rEqIFN-a. To investigate the mechanism of
resistance, the effects of EHV-1 infection on JAK-STAT signaling
pathways were analyzed. Conﬂuent monolayers of EECs were
infected with T953 strain of EHV-1 at an MOI of 5.0 and at
different times pi (3 h and 12 h), cells were stimulated with
rEqIFN-a 30 min prior to lysis for Western blotting analysis to
determine the level of endogenous as well as phosphorylated
STAT-1. Mock infected EECs stimulated with rEqIFN-a or MEM
were used as either positive or negative controls, respectively. The
results demonstrated that the virus infection not only interfered
with STAT-1 phosphorylation, but also suppressed exogenous
rEqIFN-a-induced STAT-1 phosphorylation. The ﬁndings were
further conﬁrmed by indirect immunoﬂuorescence assay which
showed that EHV-1 T953 strain prevented rEqIFN-a-induced
nuclear translocation of STAT-1 from cytoplasm. Furthermore,
this study also revealed that downstream of the JAK-STAT
signaling, EHV-1 infection inhibited expression of cellular anti-
viral proteins including IFN-stimulated gene 56 (ISG56) and
viperin. Altogether these data show that the neuropathogenic
T953 strain of EHV-1 evades the host innate immune response by
inhibiting the type-I IFN signaling pathway in EECs.
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